Spin-offs

MaxWell Biosystems has been founded on September 1^st, 2016 in Basel by four BEL collaborators, Dr. Michele Fiscella, Dr. Urs Frey, Dr. Jan Müller and Dr. Marie E. Obien. 

MaxWell Biosystems AG develops and markets high-content electrophysiology platforms to accelerate drug discovery and advance the understanding of complex neuronal systems. The company has developed high-density microelectrode arrays that enable to record electrical signals of 2D and 3D cellular preparations in vitro at network, cellular, and even subcellular level. MaxWell Biosystems has been founded in Basel and is now headquartered in Zurich. 

Shift Cryptosecurity is a spin-off company of BEL and was founded October 30th, 2015 in Basel by BEL collaborator Dr. Douglas J. Bakkum and the entrepreneur Jonas Schnelli.

Shift Crypto AG develops and markets simple and secure hardware & software products for cryptocurrency management. Their main product is the Bitbox, which is a minimalist hardware wallet in a durable and portable case that is inserted into a USB port. Private keys are stored offline in an encrypted form, including a high-security chip that protects against physical data extraction.

InSphero, another spin-off company of BEL, has been founded on March 26^th, 2009 in Zurich by the BEL collaborator Dr. Jan Lichtenberg, as well as Dr. Jens Kelm (ETH and University of Zurich) and Dr. Wolfgang Moritz (University of Zurich).

InSphero AG is a company producing and marketing 3D in vitro tissue models and offering a technological platform and expertise for drug discovery to researchers and industry clients. InSphero offers ready-to-use microtissues, microtissue assays, and 3D cell-culture solutions, which are compatible with existing laboratory automation tools. InSphero is headquartered in Schlieren, Switzerland with subsidiaries in the United States.